Clinical Trials Logo

Clinical Trial Summary

This is a prospective randomized, double-blinded, controlled trial that will enroll 75 subjects undergoing laparoscopic hiatal hernia repair surgery. Participants who meet eligibility criteria will be randomized in a 1:1 ratio to receive either the opioid sparring anesthesia protocol (OSA) or the opioid based anesthesia protocol (OBA). The purpose of this study is to investigate if an opioid sparring protocol for laparoscopic hiatal hernia repair will reduce opioid consumption during discharge. Other outcomes include: postoperative VAS scores (PACU arrival, PACU discharge, hospital discharge), total in hospital opioid consumption, PACU length of stay, incidence of postoperative nausea and vomiting (PONV in PACU, postoperative day 1, during hospital stay), rehospitalization rate, rate of reoperation, rate of emergency room visit, surgeon satisfaction, and hospital cost differential.


Clinical Trial Description

The administration of perioperative opioids to nearly 80% of surgical patients leaves approximately 6 million Americans susceptible to becoming opioid-dependent. This practice has been hypothesized as a contributing factor to the ongoing opioid crisis, where currently more than 136 Americans die from an opioid overdose every day. Recent data suggest a potential benefit of reducing perioperative opioid use, while improving the quality of surgical recovery when employing an Opioid Sparing Anesthesia (OSA) protocol with non-narcotic analgesics. More than a million hernia repairs are performed each year in the US. With the significant nationwide obesity epidemic, it is estimated that the prevalence of hiatal hernias in the western population is approximately 20%. The investigators perform hundreds of laparoscopic hiatal hernia repairs annually at NorthShore University HealthSystem. Patients routinely receive fentanyl and other opioids during this surgery to reduce pain, but opioids also increase the risk of nausea, vomiting, and ileus. In addition, these patients are often times prescribed opioids upon discharge from the hospital. Preliminary results from a small, retrospective study among laparoscopic hiatal hernia surgical patients suggested that an OSA protocol with non-narcotic analgesics (that included dexmedetomidine and ketamine) resulted in a 33% reduction in those patients requiring opioids post-discharge. Moreover, these same patients had a significant reduction in hospital length of stay and nausea/retching. Therefore, the investigators propose a double-blinded randomized controlled trial to compare the number of patients in OSA protocol vs. Opioid Based Anesthesia (OBA) protocol groups, who require no opioids within 7 days postoperatively, (a time period where our quality data suggest nearly all patients receive postoperative opioids in this population). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05953428
Study type Interventional
Source NorthShore University HealthSystem
Contact Steven Greenberg, MD
Phone 847-570-2760
Email sgreenberg@northshore.org
Status Recruiting
Phase N/A
Start date November 14, 2023
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04450628 - Esophagogastric Junction Distensibility During Hiatal Hernia Repair N/A
Active, not recruiting NCT06170060 - Treatment of Reflux With Sleeve Gastrectomy N/A
Recruiting NCT02242526 - Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia Phase 4
Active, not recruiting NCT00786084 - Study of Paraesophageal Hernia Repair With Small Intestine Submucosa N/A
Completed NCT00507377 - Foreshortened Esophagus and Its Surgical Therapy
Completed NCT05069493 - Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
Completed NCT04716166 - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery N/A
Completed NCT01776827 - Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Active, not recruiting NCT02923362 - Registry of Outcomes From AntiReflux Surgery
Completed NCT01118585 - Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) N/A
Completed NCT01195545 - Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial N/A
Recruiting NCT06432088 - Safety and Feasibility of Liver Retraction With the Levita Magnetic Surgical System: Extended Magnetic Grasper Device N/A
Recruiting NCT04936711 - Pain Relief After Hiatal Hernia Repair Surgery Phase 4
Not yet recruiting NCT04591860 - A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only N/A
Completed NCT01678157 - Use of Strattice Mesh in Paraesophageal Hernia Surgery
Completed NCT04282720 - SurgiMend Mesh at the Hiatus N/A
Not yet recruiting NCT06444347 - Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair N/A
Recruiting NCT00260585 - Esophageal Cancer Risk Registry
Active, not recruiting NCT02328248 - Usage of Biological Patch Versus Plastic in the Laparoscopic Repair of Hiatal Hernias Phase 2/Phase 3
Recruiting NCT03776669 - Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese Patients N/A